Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-05-11 19:03 | 2015-05-05 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $40.08 | 4,000 | $160,300 | 19,104 |
| 2015-05-11 22:42 | 2015-05-07 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $10.31 | 15,000 | $154,602 | 249,839 |
| 2015-05-12 03:08 | 2015-05-07 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $67.85 | 91,483 | $6,206,811 | 430,626 |
| 2015-05-11 23:15 | 2015-05-08 | BDX | BECTON DICKINSON & CO | Shabshab Nabil | Officer | OPT+S | $141.88 | 13,996 | $1,985,779 | 4,262 |
| 2015-05-11 23:10 | 2015-05-08 | BDX | BECTON DICKINSON & CO | COHEN GARY M | Officer | OPT+S | $142.90 | 13,490 | $1,927,721 | 72,315 |
| 2015-05-08 23:19 | 2015-05-07 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $64.32 | 75,000 | $4,824,203 | 956,809 |
| 2015-05-08 23:24 | 2015-05-06 | ATRC | AtriCure, Inc. | ROBARDS KAREN P | Director | OPT+S | $22.18 | 2,650 | $58,777 | 288,328 |
| 2015-05-07 23:11 | 2015-05-05 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $64.83 | 125,000 | $8,103,575 | 956,809 |
| 2015-05-08 00:16 | 2015-05-05 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $9.72 | 70,984 | $690,192 | 3,960,176 |
| 2015-05-06 23:47 | 2015-05-04 | BSX | BOSTON SCIENTIFIC CORP | Ballinger Kevin J. | Officer | OPT+S | $17.91 | 67,964 | $1,217,385 | 45,049 |
| 2015-05-07 03:44 | 2015-05-04 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $65.10 | 5,500 | $358,050 | 70,315 |
| 2015-05-06 23:12 | 2015-04-24 | CTSO | Cytosorbents Corp | Capponi Vincent | Officer | OPT+S | $7.50 | 4,000 | $30,000 | 16,724 |
| 2015-05-06 23:28 | 2015-05-04 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $9.27 | 11,000 | $101,969 | 264,839 |
| 2015-05-06 23:04 | 2015-05-04 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $9.45 | 218 | $2,060 | 41,307 |
| 2015-05-07 01:38 | 2015-05-05 | PODD | INSULET CORP | Ryan Patrick | Officer | BUY | $26.99 | 3,669 | $99,026 | 47,990 |
| 2015-05-07 01:31 | 2015-05-05 | PODD | INSULET CORP | Thomas Bradley A | Officer | BUY | $27.26 | 1,000 | $27,260 | 31,486 |
| 2015-05-07 03:07 | 2015-05-04 | DXCM | DEXCOM INC | SAYER KEVIN R | Director, Officer | SELL | $68.01 | 25,000 | $1,700,325 | 407,360 |
| 2015-05-05 20:12 | 2015-05-04 | SYK | STRYKER CORP | Owen Katherine Ann | Officer | OPT+S | $93.82 | 18,575 | $1,742,649 | 20,098 |
| 2015-05-06 00:54 | 2015-05-01 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $63.92 | 6,333 | $404,805 | 57,339 |
| 2015-05-06 03:23 | 2015-05-01 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | OPT+S | $64.56 | 36,000 | $2,324,232 | 368,599 |
| 2015-05-06 03:56 | 2015-05-04 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $67.99 | 7,500 | $509,903 | 179,741 |
| 2015-05-04 19:55 | 2015-05-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $40.74 | 4,765 | $194,139 | 147,040 |
| 2015-05-04 23:25 | 2015-04-30 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $8.90 | 4,668 | $41,545 | 41,307 |
| 2015-05-05 02:58 | 2015-04-30 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $67.68 | 34,250 | $2,317,879 | 522,139 |
| 2015-05-01 23:46 | 2015-05-01 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $13.72 | 2,000 | $27,436 | 2,235 |
| 2015-04-30 22:52 | 2014-08-12 | TTOO | T2 Biosystems, Inc. | Kalil Sarah O. | Officer | BUY | $11.00 | 5,000 | $55,000 | 5,000 |
| 2015-04-30 23:02 | 2015-04-28 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $8.99 | 15,332 | $137,806 | 41,307 |
| 2015-04-30 00:25 | 2015-04-27 | MMSI | MERIT MEDICAL SYSTEMS INC | Miller Franklin J | Director | OPT+S | $21.05 | 10,000 | $210,492 | 2,334 |
| 2015-04-30 03:39 | 2015-04-27 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | OPT+S | $68.41 | 10,000 | $684,118 | 158,811 |
| 2015-04-29 23:29 | 2015-04-27 | BAX | BAXTER INTERNATIONAL INC | STORM KORNELIS J. | Director | OPT+S | $71.05 | 4,830 | $343,172 | 16,405 |
| 2015-04-29 23:26 | 2015-04-27 | BAX | BAXTER INTERNATIONAL INC | GAVIN JAMES R III | Director | OPT+S | $71.06 | 4,830 | $343,220 | 24,173 |
| 2015-04-29 23:31 | 2015-04-27 | BAX | BAXTER INTERNATIONAL INC | STROUCKEN ALBERT P L | Director | OPT+S | $71.06 | 4,830 | $343,220 | 15,652 |
| 2015-04-27 17:36 | 2015-04-24 | SYK | STRYKER CORP | Berry William E Jr | Officer | SELL | $96.94 | 3,400 | $329,596 | 118 |
| 2015-04-28 00:50 | 2015-04-23 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $69.65 | 7,500 | $522,353 | 179,741 |
| 2015-04-24 03:09 | 2015-04-21 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $69.63 | 39,709 | $2,765,009 | 248,646 |
| 2015-04-22 18:14 | 2015-04-20 | TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Officer | OPT+S | $18.43 | 1,000 | $18,426 | 5,882 |
| 2015-04-22 21:38 | 2015-04-20 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | Officer | OPT+S | $41.55 | 4,902 | $203,676 | 37,833 |
| 2015-04-23 02:32 | 2015-04-20 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $68.05 | 7,000 | $476,352 | 109,483 |
| 2015-04-20 22:27 | 2015-04-06 | CYTX | PLUS THERAPEUTICS, INC. | Lim Kian Thiam | 10% owner | SELL | $1.37 | 600,000 | $822,540 | 7,400,000 |
| 2015-04-17 19:08 | 2015-04-15 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $73.24 | 5,975 | $437,609 | 122,356 |
| 2015-04-18 00:39 | 2015-04-15 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director | SELL | $8.55 | 17,100 | $146,244 | 336,640 |
| 2015-04-18 02:42 | 2015-04-15 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $67.56 | 15,000 | $1,013,418 | 536,389 |
| 2015-04-15 03:30 | 2015-04-10 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director | SELL | $8.42 | 6,707 | $56,499 | 353,740 |
| 2015-04-15 01:54 | 2015-04-10 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | OPT+S | $66.63 | 20,766 | $1,383,560 | 163,811 |
| 2015-04-11 02:45 | 2015-04-09 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $65.03 | 20,000 | $1,300,512 | 248,646 |
| 2015-04-11 02:44 | 2015-04-09 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $64.55 | 7,500 | $484,149 | 179,741 |
| 2015-04-11 02:44 | 2015-04-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $64.38 | 19,684 | $1,267,173 | 40,651 |
| 2015-04-11 02:41 | 2015-04-08 | DXCM | DEXCOM INC | LISTER JOHN | Officer | OPT+S | $63.84 | 5,039 | $321,680 | 131,094 |
| 2015-04-10 01:42 | 2015-02-25 | ADMD | VIVOS INC | KATZAROFF JAMES C | Director, Officer, 10% owner | BUY | $0.00 | 1,000,000 | $800 | 3,665,834 |
| 2015-04-10 01:16 | 2015-04-07 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director | SELL | $8.37 | 100 | $837 | 360,447 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.